Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paci

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Clinical Pharmacology and Therapeutics|March 30, 2007
Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumorsJ Bouligand, A Le Maitre, D Valteau-Couanet, et al.
Journal of Materials Chemistry. B|April 9, 2020
Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo resultsM T Simon-Yarza, T Baati, A Paci, et al.
International Journal of Pharmaceutics|August 15, 2017
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPECP Roy, C Canet-Jourdan, M Annereau, et al.
Journal of Endocrinological Investigation|August 22, 2024
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer networkM Faron, A Naman, J Delahousse, et al.
ESMO Open|December 5, 2021
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics studyL Cerbone, D Combarel, A Geraud, et al.
ESMO Open|December 11, 2024
Sex differences in the pharmacokinetics of anticancer drugs: a systematic reviewJ Delahousse, A D Wagner, S Borchmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursA Hollebecque, R Bahleda, L Faivre, et al.
Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Clinical Pharmacology and Therapeutics|March 30, 2007
Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumorsJ Bouligand, A Le Maitre, D Valteau-Couanet, et al.
Journal of Materials Chemistry. B|April 9, 2020
Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo resultsM T Simon-Yarza, T Baati, A Paci, et al.
International Journal of Pharmaceutics|August 15, 2017
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPECP Roy, C Canet-Jourdan, M Annereau, et al.
Journal of Endocrinological Investigation|August 22, 2024
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer networkM Faron, A Naman, J Delahousse, et al.
ESMO Open|December 5, 2021
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics studyL Cerbone, D Combarel, A Geraud, et al.
ESMO Open|December 11, 2024
Sex differences in the pharmacokinetics of anticancer drugs: a systematic reviewJ Delahousse, A D Wagner, S Borchmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursA Hollebecque, R Bahleda, L Faivre, et al.
Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.
Pageof 11